Fig. 5 | Scientific Reports

Fig. 5

From: Unlocking the therapeutic potential of Catharanthus roseus leaves via in-vitro, in-vivo, and in-silico study

Fig. 5

Structures of the major bioactive compounds showing the highest binding affinities to Catharanthus roseus, where C4) is an Ergost- 5-en- 3-ol, (3.beta.)-, C5) Stigmasterol, C6).gamma.-Sitosterol, C7) 5 H- 3,5a-Epoxynaphth[2,1-c]oxepin, dodecahydro- 3,8,8, 11a-tetramethyl-, [3 S-(3.alpha.,5a.alpha.,7a.alpha.,11a.beta.,11b.alpha.)]-, C8) 9,19-Cyclolanostan- 3-ol, acetate, (3.beta.)-, and C9) 24-Norursa- 3,12-diene.

Back to article page